Tag: U.S
Zepbound: Eli Lilly’s Obesity Drug Approved for Sleep Apnea Treatment in U.S.
Zepbound: Eli Lilly's Obesity Drug Approved for Sleep Apnea Treatment in U.S.The Food and Drug Administration made a groundbreaking announcement on Friday, granting approval...
Next U.S. Dietary Guidelines: 5 Questions and Impossible Restrictions
The Dietary Guidelines for Americans, which are updated every five years, play a significant role in shaping federal nutritional programs like WIC, school lunches,...
Impact of U.S. Election on Medicare, Drug Pricing, and AI
Health care is a significant topic in the upcoming U.S. election, with leaders from different political backgrounds sharing their views on various health care...
U.S. Ranks Last in Health Care Among High-Income Countries: Report
U.S. Health Care Ranks Last Among High-Income Countries: A Comprehensive AnalysisIn a recent report based on tens of thousands of survey responses from primary...
U.S. Increases ADHD Drug Production Limit to Alleviate Shortage
The Drug Enforcement Administration (DEA) has recently made a significant move to alleviate the ongoing shortage of ADHD medication in the United States by...
GLP-1 Weight Loss Drug: Boosting the U.S. Economy
Introduction: The Impact of GLP-1 Weight Loss Drug on the U.S. EconomyThe rise of the GLP-1 weight loss drug has sparked interest...
J&J Plan to Switch Payments for 340B Hospitals Rejected by U.S. Agency
The U.S. Health Resources and Services Administration has rejected a plan by Johnson & Johnson to change payment methods for hospitals participating in the...
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
